Our Pricing

Wegovy For Sale UK — Complete Prescribing Guide

Finding wegovy for sale uk online pharmacy options with guaranteed stock can be challenging during ongoing supply constraints. At Cured Pharmacy, we maintain consistent availability of all Wegovy doses from £79.00, with transparent upfront pricing and free clinical assessment by UK-registered prescribers.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA specifically for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the action of glucagon-like peptide-1, a naturally occurring hormone that regulates appetite and food intake by acting on areas of the brain involved in appetite regulation.

In the pivotal STEP 1 clinical trial involving 1,961 adults without diabetes, participants receiving once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Approximately 86.4% of patients on semaglutide achieved at least 5% weight loss, whilst 69.1% achieved at least 10% weight loss, and 50.5% achieved at least 15% weight loss [1].

The medication works through multiple mechanisms: it slows gastric emptying, reduces hunger signals, increases feelings of fullness after eating, and helps regulate blood sugar levels. These combined effects make it easier for patients to adhere to reduced-calorie diets and achieve sustained weight loss when used alongside lifestyle modifications [2].

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. The treatment begins at 0.25mg once weekly for the first four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [3].

This gradual titration typically takes 16-20 weeks to reach the full therapeutic dose. Our superintendent pharmacist Tarun Kumar emphasises that patients should not skip or accelerate this schedule, as doing so significantly increases the risk of nausea, vomiting, and other gastrointestinal adverse effects that may lead to treatment discontinuation.

Each Wegovy pen is pre-filled and delivers a single dose using a simple injection technique into the abdomen, thigh, or upper arm. The injection takes seconds to administer, and most patients report minimal discomfort. Consistency in timing helps maintain stable medication levels, though the specific day can be adjusted if needed with guidance from your prescriber.

Managing Side Effects During Dose Escalation

The most common side effects during the initial months include nausea (44% of patients in clinical trials), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These typically diminish as your body adjusts to each dose level. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms. If side effects become severe, your prescriber may recommend staying at your current dose for an additional month before escalating further.

Wegovy Availability and Stock Situation in the UK

The UK has experienced intermittent Wegovy supply constraints since its launch, with Novo Nordisk implementing distribution controls to manage global demand. At Cured Pharmacy, we maintain direct supply agreements and stock monitoring systems to ensure consistent availability of all five Wegovy dose strengths throughout the year.

Unlike some providers who may only stock certain doses or require patients to wait weeks for their prescribed strength, we verify stock availability before your clinical consultation begins. This means when your UK prescriber approves your treatment, your medication ships within 24 hours rather than leaving you waiting during the critical early weeks of your weight loss programme.

We recommend starting your assessment as soon as you're ready rather than waiting for perceived 'better' availability windows. Our pharmacy team proactively manages inventory levels and has contingency supplier relationships specifically to prevent treatment interruptions for existing patients.

Who Can Use Wegovy? Eligibility Criteria

Wegovy is licensed in the UK for adults with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbid condition such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [3]. Your UK prescriber will calculate your BMI during the online consultation and assess your medical history to determine suitability.

Certain medical conditions preclude Wegovy use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, diabetic retinopathy complications, and pregnancy or breastfeeding [3]. Your prescriber will also review current medications for potential interactions, particularly with other diabetes medications that may require dose adjustments.

NICE guidance recommends considering GLP-1 receptor agonists like Wegovy as part of a comprehensive weight management strategy that includes dietary modification, increased physical activity, and behavioural support. The medication enhances but does not replace these lifestyle interventions, and best outcomes occur when patients engage with all aspects of their weight management programme [4].

Assessment Process at Cured Pharmacy

Our online clinical assessment takes under three minutes to complete and covers your medical history, current medications, weight loss goals, and any previous weight management attempts. A UK-registered prescriber reviews every submission individually—we never use automated approvals. If Wegovy isn't suitable for you, your prescriber will explain why and may suggest alternative treatments that better match your clinical profile. All consultations are free, and you only pay if treatment is approved and you choose to proceed.

Wegovy vs Other Weight Loss Treatments Available in the UK

Several prescription weight loss medications are now available through UK pharmacies, each with distinct mechanisms of action, efficacy profiles, and suitability for different patient groups. Understanding these differences helps you and your prescriber select the most appropriate option for your individual circumstances.

Semaglutide-based treatments like Wegovy work through GLP-1 receptor agonism, whilst newer dual-agonist medications target both GLP-1 and GIP receptors. Older medications like orlistat work through a completely different mechanism by blocking fat absorption in the digestive system. Your prescriber will consider factors including your BMI, comorbidities, previous treatment responses, injection tolerance, and budget when recommending treatment.

Clinical trial data shows varying efficacy across different medications. The STEP trials demonstrated average weight loss of 14.9% with semaglutide 2.4mg over 68 weeks [1], whilst other treatments show different response profiles. Your individual results will depend on multiple factors including adherence to dosing schedules, dietary modifications, physical activity levels, and metabolic factors unique to you.

Switching Between Weight Loss Medications

Some patients may need to switch medications due to supply issues, side effect tolerance, inadequate response, or cost considerations. Switching between GLP-1 receptor agonists typically requires a brief washout period and restarting at a lower dose of the new medication to minimise gastrointestinal effects. Your prescriber will provide specific guidance on timing and dosing if a switch becomes necessary during your treatment journey.

Wegovy Pricing and Cost Considerations

At Cured Pharmacy, Wegovy is available from £79.00 per pen, with final pricing determined by your prescribed dose strength. We display exact prices before you complete your clinical assessment, so you know your total cost upfront with no hidden fees or surprise charges at checkout. This transparent pricing model contrasts with some providers who only reveal costs after lengthy consultations.

The total monthly cost varies during the dose escalation phase, as you'll use different strengths each month for the first 16-20 weeks before reaching the maintenance dose. Our pharmacy team can provide a complete cost breakdown for your entire titration schedule once your prescriber determines your starting point and escalation timeline.

We guarantee the lowest Wegovy prices in the UK—if you find genuine UK-licensed Wegovy advertised at a lower price from another GPhC-registered pharmacy, we'll match it. This price guarantee applies to like-for-like comparisons including the same dose strength and pen quantity. Simply contact our team on (+44) 116 4646009 before placing your order, and we'll verify and adjust your price accordingly.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. https://www.medicines.org.uk/emc/product/13799
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and the clinical data cited represents average outcomes from controlled trials. Wegovy does not cure obesity and should be used as part of a comprehensive weight management programme including dietary modification and increased physical activity.